A study evaluating responsiveness to disopyramide in patients with hypertrophic cardiomyopathy
Latest Information Update: 27 Jul 2020
Price :
$35 *
At a glance
- Drugs Disopyramide (Primary)
- Indications Hypertrophic cardiomyopathy
- Focus Therapeutic Use
- 27 Jul 2020 New trial record